“…Methyl glycolate (MG) is a valuable monomer and fine chemical intermediate because of its unique molecular structure with α-H, hydroxyl, and ester groups. It has been widely involved in the synthesis of abundant downstream products, including pharmaceuticals (such as iso-harringtonine and its analogues, which can be used as anticancer drugs), fine chemicals, perfumes, and poly(glycolic acid) (PGA, a new-generation thermoplastic polymer). , Most notably, the PGA polymer with high mechanical strength and stiffness is biocompatible and biodegradable in nature, which can be used to form biomedical materials (such as medical absorbable suture) and sustained-release materials of ecology (such as bioplastics, expected to substitute the petrochemical-based plastics). , The PGA market size was valued at USD 4.05 billion in 2019 and is expected to reach an estimated value of USD 8.30 billion by 2027, which is urgently calling for a highly efficient and cost-effective route for MG production. Currently, MG production is mainly dependent on various noncatalytic and catalytic approaches, such as the carboxylation of formaldehyde, condensation of methyl formate with formaldehyde, and hydrolysis of chloroacetic acid, − which suffer from poor efficiency, low production capacity (relative to huge PGA market demand), and harsh reaction conditions.…”